Pharma & Biotech
Coronavirus
Cannabis
Battery Metals
Psychedelics
Pharma & Biotech
Coronavirus
Cannabis
Battery Metals
Psychedelics
06:45 Wed 17 Aug 2022
The Vancouver-based company said the acquisition is accretive and builds value for shareholders by combining Doc Hygiene’s trusted line of personal sanitizer products with its growing line of science-backed nutraceutical and psychedelic products
Love Pharma (CSE:LUV) Inc said it has entered into a definitive agreement to acquire Doc Hygiene Pharmaceuticals Inc for an aggregate consideration of US$300,000.
The Vancouver-based company said the acquisition is accretive and builds value for shareholders by combining Doc Hygiene’s trusted line of personal sanitizer products with its growing line of science-backed nutraceutical and psychedelic products.
“We are thrilled to announce the acquisition of Doc Hygiene,” Love Pharma CEO Zach Stadnyk said in a statement. “We are extremely excited about Doc Hygiene’s growth potential in the years ahead and firmly believe it will provide a parallel revenue stream to our existing business in over-the-counter products.”
“Through this acquisition, the company now has a strong online eCommerce platform that will strengthen its product offering and ease of operational online sales from both a B2C and B2B standpoint,” he added.
Love Pharma said the acquisition will give it access to Doc Hygiene’s associated registered trademarks, online eCommerce sales and marketing platforms, and social media accounts. In addition, it will receive Doc Hygiene’s existing inventory of personal sanitizer products, which it negotiated at no cost to the company.
Love Pharma said it will pay for the purchase through the issuance of a convertible promissory note with a principal amount of US$150,000, payable on the fifth year of the date of issuance of the note, at an interest rate of 10% per annum, payable quarterly in arrears.
The principal amount of the promissory note shall be convertible into common shares of the company at a conversion price equal to the lessor of: (a) $0.05 per common share; and (b) the last closing price of the common shares on the Canadian Securities Exchange prior to the conversion of the note. If the conversion price is less than the minimum issue price permitted under the Canadian Securities Exchange policies (or the policies of such other stock exchange on which the common shares are listed for trading from time to time), then the conversion price shall be adjusted to be equal to the minimum price permitted under such policies of $0.05 per share.
As part of the acquisition, Love Pharma will also assume about US$150,000 of Doc Hygiene’s liabilities, it added.
Founded in 2020, Love Pharma’s mission is to bring to market innovative products that enhance sexual health and wellness, while providing an improved quality of life. It holds exclusive licenses to produce, market, package, sell and distribute patent-protected therapeutic and pharmaceutical products throughout Europe, the United Kingdom, and North America.
Contact the author at jon.hopkins@proactiveinvestors.com
Add related topics to MyProactive
Create your account: sign up and get ahead on news and events
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is…
In exchange for publishing services rendered by the Company on behalf of Love Pharma named herein, including the promotion by the Company of Love Pharma in any Content on the Site, the Company receives from said…
Prev article
Next article
Only registered members can use this feature.
or
Copyright © Proactive Group Holdings Inc, 2022
All Rights Reserved – Proactive North America Inc., Proactive Investors LLC.
Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which sections of the website you find most interesting and useful. See our Cookie Policy for more information.
Strictly Necessary and Functional
These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.
Advertising
Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.
Performance
Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.